SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $768,000 | -90.6% | 3,927 | -91.8% | 0.00% | -89.7% |
Q2 2020 | $8,180,000 | +1666.7% | 48,139 | +662.1% | 0.04% | +1200.0% |
Q1 2019 | $463,000 | +29.3% | 6,317 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $358,000 | -94.1% | 6,317 | -91.9% | 0.00% | -93.8% |
Q3 2018 | $6,027,000 | +36.0% | 78,146 | +17.1% | 0.03% | +28.0% |
Q2 2018 | $4,431,000 | +1141.2% | 66,736 | +916.5% | 0.02% | +1150.0% |
Q3 2017 | $357,000 | +4.1% | 6,565 | -0.9% | 0.00% | 0.0% |
Q2 2017 | $343,000 | -87.6% | 6,627 | -87.1% | 0.00% | -91.3% |
Q3 2016 | $2,764,000 | +386.6% | 51,181 | +218.8% | 0.02% | +360.0% |
Q1 2015 | $568,000 | -55.9% | 16,056 | -60.0% | 0.01% | -58.3% |
Q4 2014 | $1,289,000 | -40.9% | 40,131 | -16.2% | 0.01% | -50.0% |
Q1 2014 | $2,182,000 | – | 47,896 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |